FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to a pharmaceutical composition comprising a lauryl sulphate salt and a compound of formula (I), a method of preparing a composition, as well as use of a lauryl sulphate salt as a gel-preventing agent for the pharmaceutical composition.
.
EFFECT: invention enables to obtain a pharmaceutical composition of a compound of formula (I), characterised by excellent solubility properties without conversion into a gel.
19 cl, 11 tbl, 14 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| AMINOPYRAZOLE DERIVATIVE | 2010 |
|
RU2580543C9 |
| FGFR3 FUSION GENE AND PHARMACEUTICAL DRUG TARGETING SAME | 2013 |
|
RU2673943C2 |
| HETEROCYCLIC COMPOUNDS AS RET KINASE INHIBITORS | 2017 |
|
RU2742115C2 |
| SERINE/THREONINE KINASE INHIBITORS | 2013 |
|
RU2650501C2 |
| SPIROINDOLIN COMPOUNDS FOR TREATING AND PREVENTING THE RESPIRATORY SYNCYTIAL VIRUS (RSV) | 2015 |
|
RU2734248C2 |
| NEW ANTHELMINTIC QUINOLINE-3-CARBOXAMIDE DERIVATIVES | 2017 |
|
RU2772283C2 |
| DIKETONE AS INTERMEDIATE FOR 3-HALOGENE-1H-PYRASOLES | 1996 |
|
RU2251543C2 |
| INDOL-3-YL-CARBONYL-PIPERADINE-BENZIMIDAZOLE DERIVATIVES AS V1A RECEPTOR ANTAGONISTS | 2006 |
|
RU2415139C2 |
| METHOD OF PREPARING 3-HALOGENALKYL-1H- PYRAZOLES | 1996 |
|
RU2169143C2 |
| HALOGENALLILAMINE DERIVATIVES AND THEIR APPLICATIONS | 2020 |
|
RU2793850C2 |
